根据该协议,Karveer有权在印度将公司的COVID药物NV-CoV-2和NV-CoV-2-R商业化。为了实现商业化,Karveer已经进行了临床开发和评估,并为此在印度赞助了这两种药物。
蹊之美股生物医药2021-09-23 23:00
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aethlon Medical (NASDAQ:AEMD) +33%
Onconova Therapeutics (NASDAQ:ONTX) +28%
Dynavax Technologies (NASDAQ:DVAX) +26%
Candel Therapeutics (NASDAQ:CADL) +18%
BioCardia ...查看全文
蹊之美股生物医药2021-07-29 21:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI) +62%
Tilray (NASDAQ:TLRY) +25%
Grove (NASDAQ:GRVI)+20%
NeuroMetrix (NASDAQ:NURO) +2%
成纤维细胞生长因子3是一种在多种肿瘤类型,尤...查看全文
智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NANOVIRICIDES INC(NNVC)$ CORRESP [Cover] - Correspondence Filed: 2017-04-20 AccNo: 0001144204-17-021300 Size: 14 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ CORRESP [Cover] - Correspondence Filed: 2017-04-18 AccNo: 0001144204-17-020914 Size: 18 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ CORRESP [Cover] - Correspondence Filed: 2017-04-18 AccNo: 0001144204-17-020914 Size: 18 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-03-15 AccNo: 0000000000-17-008636 Size: 41 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ UPLOAD [Cover] - SEC-generated letter Filed: 2017-03-15 AccNo: 0000000000-17-008636 Size: 41 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-15 AccNo: 0001144204-17-027501 Size: 5 MB 网页链接
$NANOVIRICIDES INC(NNVC)$ EFFECT - Notice of Effectiveness Filed: 2017-04-25 AccNo: 9999999995-17-000938 Size: 1 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2017-04-18 AccNo: 0001144204-17-020912 Size: 708 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2017-03-01 AccNo: 0001144204-17-011857 Size: 731 KB 网页链接
$NANOVIRICIDES INC(NNVC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-02-14 AccNo: 0001144204-17-009000 Size: 6 MB 网页链接